© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Pharmaceuticals tend to reflect the times they emerge from. Carbetapentane citrate has roots tracing back to the late 1940s, part of that rush for safer and more reliable cough remedies in the post-war era. The search for non-narcotic antitussives led to years of trial and error. Early attempts often led to unpredictable central nervous system side effects. Then came carbetapentane, bringing relief without the typical narcotic baggage. Doctors soon picked up on its utility in practice, recommending it for both adults and kids struggling with dry, hacking coughs that just wouldn’t let up. Pharmacies saw it slide onto shelves, a modern solution at a time when people were scarred by the drawbacks of old-school cough suppressants.
Carbetapentane citrate appears as a mainstay ingredient in many over-the-counter cough mixtures. Sharply focused on that pesky, non-productive cough, its presence signals a shift away from opioid-based remedies. The compound’s mild effect on the cough center in the brain, along with a reputation for being less sedating, satisfies the daily needs of families and physicians alike. It pops up in syrup form, drops, and sometimes as a stand-alone ingredient in generic cough formulas. The clear appeal: a product trusted by parents and recommended by healthcare providers who favor symptom relief over sedation.
Looking at the substance itself, carbetapentane citrate forms a white or off-white, odorless, crystalline powder. Solubility hits the right note for pharma—readily mixes in water. The molecular formula stands as C14H22ClNO·C6H8O7, with its chemical structure showing off an ether and a tertiary amine, assembled around a piperidine ring and paired with citric acid to create the salt form. This pairing controls the medicine’s delivery, making it shelf-stable and easy to handle. Melting point falls in the 85-95°C range. Stability remains firm under most storage conditions found in clinics and homes, a plus for distribution and use in varied climates.
On the technical front, pharmaceutical manufacturers outline very specific standards for every batch of carbetapentane citrate. Purity stays tightly controlled, usually above 98%. Impurities, moisture levels, and residual solvents all get tracked. Labels on commercial products include standardized measurements—typically stating 10 mg per 5 ml dosage for liquid formulations. There’s always a nod to the need for precise dosing—especially given the child-friendly nature of many carbetapentane products. The US Pharmacopeia, along with the European Pharmacopeia, lists identification tests, chemical purity checks, and packaging expectations, ensuring the product is safe from contamination and correctly labeled for those who need it most.
Manufacturing moves through several well-established steps. Starting with 1-(2-dimethylaminoethoxy)-3-chloropropane, chemists work through controlled reactions with piperidine to set up the core structure. The resultant base gets neutralized with citric acid to make the citrate salt, which allows for straightforward formulation into liquid or tablet forms. Modern methods focus on reproducibility, cost-effectiveness, and compliance with good manufacturing practices, where cleanliness and quality management drive every decision. The process doesn’t demand exotic equipment, but the makers still maintain rigorous checks to avoid errors during synthesis or finishing.
Pharmaceutical companies care about how chemicals break down—or hold together—across a spectrum of conditions. Carbetapentane stands up well under standard processing environments, resisting unwanted hydrolysis or breakdown unless pushed into very acidic or basic conditions. Some recent research plays around with esters and related compounds, tweaking the base molecule to look for less toxic or more potent derivatives. Most of this chemical adaptation still sits at the research level, with clinical benefits yet to earn broad acceptance.
Depending on where you shop or whom you ask, carbetapentane citrate also shows up as pentoxyverine citrate, pentoxyverin, or under branded names that have enjoyed decades of market presence. Retail pharmacists might stock brands that have dominated shelves since the 1960s, while generic variants appear under simpler monikers in pharmacy databases. This multiplicity of names sometimes leads to confusion among patients, especially when they’re used to older products—so clear pharmacy labeling and timely advice always helps navigate the mix.
Over years of use, carbetapentane citrate has chalked up a track record most clinicians feel good about—especially compared to codeine-based alternatives. The main safety concerns revolve around misuse, especially with children and those taking multiple medications. Operational standards fall in line with FDA and EMA guidelines, spelling out manufacturing controls, batch testing, and proper packaging to prevent child access. Commercial products always urge dosing only as directed, building in safety tops on syrups and adding warning labels about interactions with sedatives or alcohol.
Most carbetapentane ends up in community pharmacies and hospital storerooms, answering calls for help from people fighting nagging, dry coughs. Doctors often pick it for patients with irritable airways, bronchitis, or cold-induced cough that won’t quit after standard remedies. Kids and elderly folks make up much of the regular user base, looking for symptom relief without sedation or constipation caused by narcotic antitussives. Some research teams investigate whether carbetapentane could do more than cough relief, testing it in new clinical settings, but cough suppression remains its bread and butter.
Research on carbetapentane citrate continues, though not as aggressively as for new antivirals or cancer medications. Investigators look at metabolic pathways, drug interactions, and long-term effects on the developing brain, especially with young children who might need repeated doses during the winter months. Universities and pharma companies also keep up with post-marketing surveillance, noting rare allergic reactions or misuse trends. In recent years, renewed interest in non-narcotic cough suppressants has inspired a few fresh angles, with teams digging into formulation science, taste masking, and potential benefits beyond cough control—sometimes with positive early results but rarely with game-changing breakthroughs yet.
Toxicologists measure everything, from mouse models to accidental overdoses in children, to catch any red flags early. Acute toxicity for carbetapentane remains low relative to old-school opiates. Symptoms of overdose tend to include mild confusion, sleepiness, and in rare cases, cardiac changes, but more serious harm mostly comes from major overdoses. Regulatory agencies expect ongoing safety tracking through pharmacovigilance networks, which catch trends that might escape clinical trials. Animal studies assess mutagenicity and teratogenicity. So far, published reports suggest minimal long-term harm, though every few years, new data prompt a close review by health authorities.
Looking ahead, changes in how cough and cold medicines get regulated will push drugmakers to innovate. Demand for non-addictive, effective cough suppressants shows no sign of slowing. Technology may soon deliver new, even safer derivatives, while consumer groups push for better transparency about ingredient sourcing and side effect profiles. As regulatory landscapes move ever tighter—especially for children’s products—manufacturers tweak formulations and delivery methods to maximize compliance and minimize risk. Sustainability concerns also play a role, with pressure mounting to cut waste in packaging and streamline manufacturing footprints. The next few decades could see carbetapentane citrate either fade as other compounds take center stage, or find new life through clever chemistry and smarter supply chains—time and consumer trust will draw the line.
Carbetapentane citrate doesn’t show up on every pharmacy shelf, but folks dealing with a nagging cough know it by its promise: relief. This compound works inside many prescription cough syrups, fighting coughs at their source. It targets the brain’s cough center. That means, instead of quieting a sore throat, it reaches for the root of the problem and helps stop the urge to cough even before you feel it.
For someone who’s been through months of sleepless nights thanks to a stubborn cough, a medicine that acts directly on the nervous system feels almost like a miracle. While some other cough suppressants, like codeine, carry the risk of addiction or drowsiness, carbetapentane stands out for offering relief with a better safety record in those areas. It doesn’t get the same scrutiny that codeine does, so it’s favored for older kids and people who want to steer clear of narcotics.
Carbetapentane citrate treats cough tied to colds, allergies, throat irritations, and even smoke. Doctors keep it in the toolbox for cases where something keeps irritating the airways, not so much for coughs that bring up a lot of mucus. That’s key—suppressing a productive cough can trap what the body tries to clear out. In my own experience helping my son muddle through winter bugs, the pharmacist laid it out clearly: use it when the cough keeps him up or steals his appetite, not just out of habit.
Every medicine brings its own baggage. Carbetapentane can cause dizziness, upset stomachs, and dry mouth. Sometimes people feel lightheaded or a bit off their game, which can throw off tasks like driving. Mixing it with alcohol or other sedatives isn’t smart because the combined effects can sneak up on you.
Kids under two should never take medicines like this unless a doctor gives the green light. The FDA has flagged risks in young children, so extra care matters. Pregnant people and those with health problems such as liver disease should also check with a doctor before starting any new cough medicine.
Many households rely on quick fixes for coughs, but not all remedies match every cough, or everyone’s needs. While carbetapentane’s not as common as over-the-counter cough suppressants, it earns trust among doctors who want a non-opioid choice for tough coughs. It doesn’t have the same street value or risks as codeine or hydrocodone, but it still needs respect.
Uncontrolled cough disrupts more than just sleep. It weakens the body, drains energy, and stresses families. Medicines like carbetapentane citrate aren’t miracle cures, but they hold an important place for those who struggle to shake off a cough that just won’t quit.
The real answer isn’t always more medicine. Staying hydrated, avoiding throat irritants, and tackling allergies help prevent many coughs before they start. Doctors and pharmacists serve as guides, not just prescription fillers, and it pays to ask questions. Understanding what carbetapentane citrate does and when it helps can make the difference between pointless dosing and real relief. Trust in conversations, not just in quick fixes from a bottle.
Carbetapentane Citrate steps into the scene as an ingredient in some cough syrups. Anyone sitting through a lingering cough knows the routine: scan the medicine cabinet, hope for something that won’t leave you drowsy. Carbetapentane claims to knock out coughs without the narcotic baggage some other syrups bring. But let’s get real about side effects. Every cough remedy flips a coin with your body’s chemistry, and Carbetapentane is no different.
I remember using cough suppressants during college’s allergy season, desperate for sleep. My own body reacted with a dry mouth and headaches. Studies back that up. Users often report that dry mouth shows up early, not far behind is a lingering sense of lightheadedness. Tiredness sneaks in, too. Anyone running a busy household or juggling work meetings can’t brush off that drained feeling. Nausea chimes in, sometimes bad enough to interrupt your day. These aren’t rare stories; pharmacists hear them all the time when folks ask if they can tough it out at home.
Every so often, something more severe rolls through. Some folks find themselves struggling to urinate, especially older adults or those with prostate issues. That kind of challenge disrupts everyday life and signals a clear reason to see a doctor. Fast or irregular heartbeats get reported, too, particularly if a larger dose sneaks into your routine. Watch out for confusion or blurred vision. These shake up your sense of safety and daily function. WebMD and medical journals lay this out in black and white—these are red flags, not just inconveniences.
Personal experience and the stories of people close to me underline one key point: it’s usually tempting to brush off a “mild” side effect. People working multiple jobs or looking after kids prefer to power through. But data shows too much product stacking—taking multiple meds with the same ingredient, or accidentally exceeding the correct dose—can increase risk. For someone with asthma, heart conditions, or glaucoma, every extra side effect matters. The FDA keeps this ingredient under a watchful eye for those reasons.
Doctors sometimes recommend tracking new symptoms on paper. Jotting down experiences—how often headaches arrive, whether sleep seems different, if moods shift—creates a real-world map of how a medication treats your body. Printed pamphlets help, but firsthand notes drive smarter conversations with your healthcare provider. Pharmacists serve as easy checkpoints, too. They spend all day fielding questions about drug combinations and strange reactions, drawing on years of training most people never see.
Open conversations matter most. Don’t wait for a full-blown event to ask questions. I’ve seen communities benefit from local pharmacists hosting Q&A’s about over-the-counter medications. Online patient forums help fill the gaps when official sources sound too technical. Public health sites like the Mayo Clinic and CDC post clear guidelines—reading these before diving into self-treatment pays off, especially for folks with chronic conditions or on multiple medications. Sticking to prescribed dosage, skipping alcohol, and informing doctors about every medication on your list helps keep serious side effects at bay. Safety grows from honest discussion, shared experience, and a solid dose of self-awareness.
People hunt for relief when a cough just won’t quit. Carbetapentane Citrate shows up in pharmacies as a go-to cough suppressant. It works by helping calm the urge to cough, offering a break from that constant throat-tickling that wears a person down. I’ve spent my fair share of nights listening to my own cough echo off the walls and know the type of frustration that pushes folks to try nearly anything for some peace.
Dosing isn’t a guessing game. Most doctors match the amount to how old you are and how your body handles medicine. The label gives the recommended amount, but I always double-check with my pharmacist. Swallowing the dose straight from the bottle often causes trouble down the line — spills, wrong amounts, sticky messes. A marked measuring spoon or cup actually exists for a reason; using it takes away worry about overdoing it.
Doctors stress timing. Too close together? You risk taking too much, even if you convince yourself the cough deserves it. Too far apart? The relief slips away, and the coughing wakes you at night. Most folks take it every four hours, not more than four doses a day. Missing one usually just means getting back on track with the next regular dose. Trying to double up never works in a patient’s favor.
Mixing different medicines at home isn’t as easy as it sounds. Plenty of cough syrups contain extra stuff — like antihistamines, pain killers, or even alcohol. Some ingredients knock you off your feet, others dry you out, and some come with a warning label for a reason. Before stacking it with anything else, I always stop to talk to a pharmacist. They catch risky mixes I never would have considered.
Kids remain especially vulnerable. Cough medicine for grown-ups rarely works out well for little ones. Their bodies process things differently, and what’s safe for someone weighing 180 pounds often causes trouble in a growing kid. Pediatricians guide parents on what works best, how much to give, and what signs mean it’s time for a real visit.
Carbetapentane Citrate isn’t sugar water. Sometimes folks break into a rash, get the shakes, or feel dizzy. Heart racing, trouble breathing, or odd thoughts — those aren’t things to ignore. Instead of pushing through, speaking up to your doctor makes all the difference. I’ve seen close friends land in the ER just by ignoring minor problems until they exploded.
Most people won’t run into trouble, but having a list of everything you already take (herbal tea, vitamins, prescription drugs) helps the doctor spot risky combinations in a hurry. That sort of basic honesty turns “taking another spoonful” into responsible treatment rather than just hoping for quiet.
Old bottles in bathroom cabinets grow bacteria and lose strength. When in doubt, trash the expired stuff. Also, dosing more isn’t a shortcut to recovery; it just opens the door for more problems, sometimes even liver damage. Keeping cough medicine away from kids’ reach seems obvious, but accidents in tired homes happen all the time. I’ve seen one close call settle a debate for life.
Ultimately, the doctor’s instructions matter most. Trusting their experience, sticking with their plan, and checking in if something feels off — that sort of approach actually helps people recover quicker and with less stress.
Good rest, plenty of water, and being honest about other health issues give your body a solid shot at beating a cough. Cough medicine like Carbetapentane Citrate does the heavy lifting for symptoms, but the basics — sleep, hydration, monitoring your own reactions — make the difference between a speedy recovery and a drawn-out illness.
Every parent worries about what goes into their child’s body, especially during seasonal waves of coughs and colds. Carbetapentane citrate often pops up in over-the-counter cough syrups and prescription cough suppressants. Most people recognize it as a cough suppressant that quiets a nagging, dry cough. The question that hangs in the air is how safe it is for young kids.
Pediatricians often stress that kids’ bodies don’t process drugs the same way adults do. Carbetapentane citrate works by affecting the part of the brain responsible for the cough reflex. In my experience, many parents trust anything on a pharmacy shelf, but the FDA hasn’t approved this ingredient specifically for children under two. That gap alone should prompt caution.
Data on safety in older children is thin. Clinical studies focus largely on adults, and the few published pediatric studies tend to use small groups. Without robust evidence, medical organizations, including the American Academy of Pediatrics, often urge parents to be wary of cough suppressants in children. Risks run from sleepiness and irritability to more serious side effects, such as trouble breathing or rapid heart rate.
Doctors see some common side effects like stomach upset, dizziness, and a general sense of drowsiness. More troubling, though much less common, are allergic reactions or changes in breathing. As someone who’s raised two kids through the toddler years, seeing a child have difficulty breathing isn’t something any parent wants to face, especially from something that’s supposed to help.
Reports often highlight accidental overdoses in little ones. Most cases trace back to giving more than one cough or cold medicine at a time, which can lead to dangerous interactions. In my own circle, I’ve known parents who carefully read labels, but I’ve also heard of rushed evenings when medicine was grabbed in a hurry because a child couldn’t sleep.
Several studies repeat the same finding: cough syrups rarely do much for small children. Honey (in kids over a year old), humidifiers, and simple saltwater rinses often bring more comfort than a bottle of medication. Good rest and time give the body a fighting chance to heal.
The World Health Organization and leading pediatric groups recommend patience and supportive care as the primary response for a mild cough. Each time my children caught a cold, I leaned on fluids and rest, and checked in with their doctor before considering anything stronger than a warm drink.
Parents should read every label and check with a pediatrician before reaching for carbetapentane citrate. Be cautious about combining medicines, especially those with similar active ingredients. Families can help prevent accidents by keeping all medication out of a child’s reach, storing bottles up high and well out of sight.
For any child with difficulty breathing, a cough that won’t quit, or other unusual symptoms, a doctor’s advice beats self-medicating every time. Staying informed means trusting reliable health sources and leaning on medical experts—not just advertisements or word-of-mouth suggestions from friends.
Questions about mixing cough syrup with other medications come up in almost any pharmacy or doctor's office. Carbetapentane citrate targets cough, helping folks breathe easier during colds or other respiratory troubles. Yet, pairing it with other medicines often causes worry, especially for people juggling prescriptions for multiple conditions.
Someone taking carbetapentane often manages high blood pressure, diabetes, allergies, or maybe chronic pain. Every pill, capsule, or tablet comes with its own set of chemical rules, and some don’t get along with others. Researchers and physicians see drug interactions every day—some mild, some serious enough to make a person land in the hospital.
Carbetapentane citrate can increase drowsiness, especially if combined with antihistamines, sleep medicines, anxiety medications, alcohol, or strong painkillers. I have witnessed people come in feeling extra sleepy or dizzy, a direct result of this drug mix. For older adults, these mix-ups can increase the risk of falls or confusion.
Many years behind a pharmacy counter showed me how easy it is to mix up medicines at home. Someone once came in after taking carbetapentane along with a common cold-and-flu combo, anything bought easily at the corner store. The result: dry mouth, a pounding heart, and anxiety—something anyone would find frightening. That’s just one story, but it serves as a reminder to always ask before combining over-the-counter and prescription drugs.
Medical training covers these topics, but patients receive bottles of pills, not textbooks. Everyone is unique; what triggers a bad reaction in one person might be mild in another. Still, the same drug classes continue to flag problems. Antidepressants, high blood pressure drugs, anti-seizure medicines, and even herbal supplements can run into trouble in the liver, kidneys, or brain when combined with carbetapentane.
Science backs this up. Studies report that mixing medications is responsible for more than 100,000 hospital admissions in the United States every year. Many of these visits could be prevented with clear questions at the doctor’s office or the pharmacy window.
A simple list on your phone or in your wallet keeps track of every medicine. Show this list to your pharmacist each time you buy a new remedy—prescription or over-the-counter. Speaking up with, “Can I take these together?” saves headaches, hospital stays, and money.
Online databases from reputable sources, like the FDA or Mayo Clinic, provide information, but conversation with a healthcare provider trumps them every time. Health professionals know your health history and spot risky combinations quickly.
Something as simple as calling your pharmacist or nurse can stop a dangerous mistake. Don’t wait for side effects to pile up. Open communication helps every patient get the benefits of their medication, without unneeded risks.
| Names | |
| Preferred IUPAC name | 3-(2-Dimethylaminoethoxy)-2-phenyl-1-propanol citrate |
| Other names |
Pentoxyverine Citrate Pentoxyverine Citrate of Carbetapentane |
| Pronunciation | /karˌbiːtəˈpɛnˌteɪn ˈsɪtreɪt/ |
| Identifiers | |
| CAS Number | 125-73-5 |
| Beilstein Reference | 1109286 |
| ChEBI | CHEBI:94631 |
| ChEMBL | CHEMBL2104748 |
| ChemSpider | 110409 |
| DrugBank | DB00547 |
| ECHA InfoCard | 1007006 |
| EC Number | 211-371-6 |
| Gmelin Reference | 80906 |
| KEGG | D07677 |
| MeSH | Dextromethorphan |
| PubChem CID | 65314 |
| RTECS number | GV7875000 |
| UNII | A6X3V09I2K |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C19H23NO7 |
| Molar mass | 525.55 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | Density: 1.2 g/cm³ |
| Solubility in water | Very soluble in water |
| log P | 0.3 |
| Acidity (pKa) | ~9.1 |
| Basicity (pKb) | 2.93 |
| Magnetic susceptibility (χ) | -72.5e-6 cm³/mol |
| Refractive index (nD) | 1.586 |
| Dipole moment | 0.00 D |
| Pharmacology | |
| ATC code | R05DB21 |
| Hazards | |
| Main hazards | May cause respiratory depression, drowsiness, dizziness, nausea, vomiting, and allergic reactions. |
| GHS labelling | GHS labelling: "No GHS classification |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | No hazard statements. |
| Precautionary statements | Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. |
| Flash point | 84.5°C |
| Lethal dose or concentration | LD50 (oral, rat): 825 mg/kg |
| LD50 (median dose) | LD50 (median dose): 825 mg/kg (rat, oral) |
| NIOSH | CJ8FYQ7T42 |
| PEL (Permissible) | PEL (Permissible exposure limit) for Carbetapentane Citrate: Not established |
| REL (Recommended) | 10 mg |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Pentoxyverine Butamirate Cloperastine Dextromethorphan Levodropropizine |
